发明名称 |
PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS |
摘要 |
The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor. |
申请公布号 |
WO2013068347(A1) |
申请公布日期 |
2013.05.16 |
申请号 |
WO2012EP71933 |
申请日期 |
2012.11.06 |
申请人 |
SANTARIS PHARMA A/S |
发明人 |
HAGEDORN, PETER;PETRI, ANDREAS;LINDOW, MORTEN;KAUPPINEN, SAKARI |
分类号 |
C12Q1/70;G01N33/576 |
主分类号 |
C12Q1/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|